| Term 
 
        | Primary MOA: increases/replaces insulin secretion |  | Definition 
 
        | insulin, SUs, meglitinides |  | 
        |  | 
        
        | Term 
 
        | Primary MOA: decreases heaptic glucose output |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Primary MOA: decreases glucagon, which decreases glucose production |  | Definition 
 
        | GLP-1, DPP-4, pramlintide |  | 
        |  | 
        
        | Term 
 
        | Primary MOA:  slows gastric emptying, which increases satiety |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Primary MOA: Increases glucose excretion |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Primary MOA: Increases insulin sensitivity |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immunne destruction of beta cells --> No insulin production -->  No muscle uptake of glycogen --> Fat production --> Keytone production --> DKA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Damged beta cells  -->  Decreased insulin production |  | 
        |  | 
        
        | Term 
 
        | Describe HYPERglycemia symptoms |  | Definition 
 
        | 3 polys (polyuria, polydypsia, polyphagia) blurry vision
 fautigue
 unexplained weight loss
 |  | 
        |  | 
        
        | Term 
 
        | Describe HYPOglycemia symptoms |  | Definition 
 
        | Shaky, Irritable, HA, Hunger, Confusion, Weak, Sleepy, Dizzy, Sweaty, Tachcardia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | FPG: 100-125 2Hr Plasma Glucose after 75mg OGTT: 140-199
 A1C: 5.7-6.4
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | FPG: ≥ 126 2Hr Plasma Glucose after 75mg OGTT: ≥ 200
 A1C: ≥ 6.5
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A1C: < 7% preprandial glucose: 80-130
 postprandial glucose: < 180
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | SCr: 1.5 males | 1.4 females |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2000-2550 depending on the dosing form |  | 
        |  | 
        
        | Term 
 
        | Metformin causes ____ deficency. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | GI upset; less with ER; will improve with time Ghost tablet in stool with ER
 Stop before/after contrast dye (48h)
 |  | 
        |  | 
        
        | Term 
 
        | Does metformin have hypoglycemia risk? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Meglitinides brand/generic (2 drugs) |  | Definition 
 
        | repaglinide (Prandin) nateglinide (Stralix)
 |  | 
        |  | 
        
        | Term 
 
        | Take meglitinides __________ |  | Definition 
 
        | 30 min before meals (like insulin) |  | 
        |  | 
        
        | Term 
 
        | Solfnyureas: brand/generic (3 drugs) |  | Definition 
 
        | glipizide (Glucotrol) glimepiride (Amaryl)
 glyburide (Glynase)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Take @ breakfast Take glipizide (Glucotrol IR) before meals
 Sulfa-based
 2C9 substrates
 |  | 
        |  | 
        
        | Term 
 
        | Thiazolidinedones: brand/generic |  | Definition 
 
        | pioglitazone (Actos) rosiglitazone (Avandia)
 |  | 
        |  | 
        
        | Term 
 
        | Thiazolidinedones: pearls |  | Definition 
 
        | TZDs are 2C8 substrates (rifampin/gemfibrozil) S/E: edema, weight gain
 Cause: liver fail, bone density loss, HF
 |  | 
        |  | 
        
        | Term 
 
        | Sodium Glucose Co Transporter (SGLT2): brand/generic (3 drugs) |  | Definition 
 
        | canagliflozin (Invokana) dapagliflozin (Farxiga)
 empagliflozin (Jardiance)
 |  | 
        |  | 
        
        | Term 
 
        | Sodium Glucose Co Transporter (SGLT2): pearls |  | Definition 
 
        | Similar action to diurectics SGLT2s are flozin the sugar out!
 Glucose excretion --> UTIs + yeast infections
 Leg/foot amputations
 |  | 
        |  | 
        
        | Term 
 
        | Glucagon like peptide 1 agonist: brand/generic (5 drugs) |  | Definition 
 
        | exantide (Byetta/Bydureon) liraglutide (Victoza)
 dulaglutide (Trulicity)
 albiglutide (Tanzeum)
 Lixisenatide (Adlyxin)
 |  | 
        |  | 
        
        | Term 
 
        | Pramlintide brand/generic |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | DI due to MOA (slowing gastric emptying): Antibiotics / Contraception S/E: N/V/D, HA, (decreases over time)
 SQ inj
 Stomach pain = pancrease problem = STOP
 Not for folks with self/fam thyroid cancer
 |  | 
        |  | 
        
        | Term 
 
        | Exantide (Byetta): pearls |  | Definition 
 
        | BID; AM/PM before meals 60 doses per pen = 30days
 |  | 
        |  | 
        
        | Term 
 
        | Exantide (Bydureon): pearls |  | Definition 
 
        | Inject immediately after mixing powder/liquid |  | 
        |  | 
        
        | Term 
 
        | Liraglutide (Victoza): pearls |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Bydureon, Trulicity, Tanzeum dosing interval? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Separate from insulin by 3hrs Decrease insulin meal time dosing by 50% to prevent hypoglycemia
 |  | 
        |  | 
        
        | Term 
 
        | DDP4 inhibitors brand/generic (4 drugs) |  | Definition 
 
        | Sitagliptin (Januvia) Saxagliptin (Onglyza)
 Linagliptin (Tradjenta)
 Alogliptin (Nesina)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DDP4s are glucagon-free gliptin tea linagliptin + saxagliptin are 3A4 and Pgp substrates
 Qday dosing - Food does not matter
 Stomach pain = pancrease problem = STOP
 Saxagliptin + algogliptin --> HF; trouble breathing = STOP
 |  | 
        |  | 
        
        | Term 
 
        | Rapid acting insulin: brand/generic (4 drugs) |  | Definition 
 
        | Aspart (Novolog) Glusine (Apidra, Solostar)
 Lispro (Humalog) **kwikpen = 200u/mL
 Afrezza ***inhaled
 |  | 
        |  | 
        
        | Term 
 
        | Regular insulin: brand/generic (2 drugs) |  | Definition 
 
        | Humlin R, Humlin R U-500 *500u/mL
 Novolin R
 |  | 
        |  | 
        
        | Term 
 
        | Intermediate "basal" insulin: brand/generic (2 drugs) |  | Definition 
 
        | NPH (Humlin N, Novolin N) |  | 
        |  | 
        
        | Term 
 
        | long-acting "basal" insulin: brand/generic (3 drugs) |  | Definition 
 
        | Detemir (Levimir) Glargine (Lantus, Basaglar, Toujeo)
 Degludec (Tresiba)
 |  | 
        |  | 
        
        | Term 
 
        | Mixed insulin: brand/generic (4 drugs) |  | Definition 
 
        | Novolog Mix 70/30 = 70% protamine, 30% aspart Novolin Mix 70/30 = 70% NPH, 30% Humlin
 Humalog Mix 75/25 =75% protamine, 25% lispro
 Humalog Mix 50/50 =50% protamine, 50% lispro
 |  | 
        |  | 
        
        | Term 
 
        | Most insulin product are ___units/mL.  What are 4 exceptions? |  | Definition 
 
        | most products = 100u/mL Humalog kwikpen = 200u/mL
 Humulin R U-500 = 500u/mL
 Tresiba = 200u/mL
 Toujeo Solostar = 300u/mL
 |  | 
        |  | 
        
        | Term 
 
        | Most insulin pens are ___mL, with one exception _________ . |  | Definition 
 
        | Most pens are 3mL Toujeo = 1.5mL
 |  | 
        |  | 
        
        | Term 
 
        | Most insulin pens have _____ unit increments, with two exceptions _____________, _____________ . |  | Definition 
 
        | Most pens; 1 increment = 1 unit Humulin R u-500; 1 increment = 5 units
 Tresiba Flextouch; 1 increment =2 units
 |  | 
        |  | 
        
        | Term 
 
        | What types of insulin is used in insulin pumps? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | When converting between insulin brands reduce dosage by |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How to dose insulin?  (3 steps) |  | Definition 
 
        | 1.    0.6u/kg/day = Total Daily Dose (TDD) 2.   Divide TDD by 2 to determine Total basal dose and total bolus dose
 3.   Further divide total bolus dose by 3 to determine meal-time dosing
 |  | 
        |  | 
        
        | Term 
 
        | Describe the rule of 450 and 500 |  | Definition 
 
        | Determines the insulin to carb ratio. 500/TDD = g of carb covered by 1U of rapid acting insulin
 450/TDD = g of carb covered by 1U or regular insulin
 |  | 
        |  | 
        
        | Term 
 
        | Describe the rule of 1800 and 1500 |  | Definition 
 
        | 1800/TDD = corr. factor for rapid acting insulin 1500/TDD = corr. factor for regular insulin
 
 (BG Now - Target BG)/corr. factor = corr. dose
 |  | 
        |  | 
        
        | Term 
 
        | When mixing insulin which type is drawn up first? |  | Definition 
 
        | 1rst Clear (regular) 2nd Cloudy (NPH)
 ****These are the ONLY types of insulin that can be mixed****
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BG ≤ 70. TX with 15-20g SIMPLE carbs repeat Q15min PRN
 |  | 
        |  | 
        
        | Term 
 
        | Drugs that cause hypoglycemia |  | Definition 
 
        | linezolid lorcaserin (Belviq)
 Octreotide
 pentamidine
 Propanolol
 Quinine
 Quinolones
 |  | 
        |  | 
        
        | Term 
 
        | Drugs that cause hyperglycemia |  | Definition 
 
        | B blockers diuretics
 immunosuppressents
 naicin
 Pis
 Quinolones
 2nd gen AP
 Statins
 Steroids
 Azole AF
 |  | 
        |  |